Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18250412rdf:typepubmed:Citationlld:pubmed
pubmed-article:18250412lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C0025926lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C1513867lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C1416467lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C1418401lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:18250412lifeskim:mentionsumls-concept:C1998811lld:lifeskim
pubmed-article:18250412pubmed:issue4lld:pubmed
pubmed-article:18250412pubmed:dateCreated2008-2-5lld:pubmed
pubmed-article:18250412pubmed:abstractTextSystemic lupus erythematosus is an autoimmune disease caused primarily by autoantibodies (including IgG anti-DNA) and immune complexes that cause tissue damage. After tolerization with an artificial peptide (pConsensus, pCons) based on murine anti-DNA IgG sequences containing MHC class I and class II T cell determinants, lupus-prone (NZB x NZW)F(1) female (BWF(1)) mice develop regulatory CD4+CD25+ T cells and inhibitory CD8+ T cells, both of which suppress anti-DNA Ig production and immune glomerulonephritis. In the present work, we show that splenocytes from BWF(1) mice treated with pCons had significant expansion of primarily CD8+ T cells. CD4+ T cells and B cells were each directly suppressed by CD8+ T cells from tolerized mice in a contact-independent manner. Both pCons-induced CD8+CD28+ and CD8+CD28- T cells suppressed production of anti-DNA in vitro. Silencing with small interfering RNA of Foxp3 abrogated the suppression mediated by both CD8+ T cell subsets. Additionally, CD8+ T cells from tolerized mice were weakly cytotoxic against syngeneic B cells from old anti-DNA-producing mice, but not from young mice. Importantly, pCons treatment had dual effects on CD8+ suppressor T cells from tolerized mice, increasing the intracellular expression of Foxp3 while decreasing the surface expression of PD1 molecules. Blocking PD1/PDL1 interactions in the CD8+ T cells from tolerized mice reduced their expression of Foxp3 and their ability to suppress CD4+CD25- proliferation. In contrast, blocking PD1/PDL1 in naive T cells increased Foxp3 expression. Our data suggest that tolerization with pCons activates different subsets of inhibitory/cytotoxic CD8+ T cells whose targets are both CD4+CD25- effector T cells and B cells.lld:pubmed
pubmed-article:18250412pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:languageenglld:pubmed
pubmed-article:18250412pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250412pubmed:statusMEDLINElld:pubmed
pubmed-article:18250412pubmed:monthFeblld:pubmed
pubmed-article:18250412pubmed:issn0022-1767lld:pubmed
pubmed-article:18250412pubmed:authorpubmed-author:HahnBevra HBHlld:pubmed
pubmed-article:18250412pubmed:authorpubmed-author:La...lld:pubmed
pubmed-article:18250412pubmed:authorpubmed-author:SinghRam...lld:pubmed
pubmed-article:18250412pubmed:issnTypePrintlld:pubmed
pubmed-article:18250412pubmed:day15lld:pubmed
pubmed-article:18250412pubmed:volume180lld:pubmed
pubmed-article:18250412pubmed:ownerNLMlld:pubmed
pubmed-article:18250412pubmed:authorsCompleteYlld:pubmed
pubmed-article:18250412pubmed:pagination2069-80lld:pubmed
pubmed-article:18250412pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:meshHeadingpubmed-meshheading:18250412...lld:pubmed
pubmed-article:18250412pubmed:year2008lld:pubmed
pubmed-article:18250412pubmed:articleTitlepConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.lld:pubmed
pubmed-article:18250412pubmed:affiliationDivision of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, 1000 Veteran Avenue, Los Angeles, CA 90095, USA. rpsingh@mednet.ucla.edulld:pubmed
pubmed-article:18250412pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18250412pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18250412pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18250412lld:pubmed